Deitsch Stephen
Transaction: 06/11/2026
BUY
Change
+20,000
Price
Not reported
Filing
06/12/2026
Type
BUY
Aclarion, Inc.
ACON • Medical - Healthcare Information Services
$1.97
▲ +0.08 (+4.23%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$4.92M
Growth
-74.7%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 14.81Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 1:14 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.97
Change4.23%
Shares Out2.46M
Market Cap$4.92M
Enterprise Value$-11.36M
52W Range1.95 - 12.03
Beta1.22
P/E-0.54
P/S58.79
P/B0.29
P/FCF-0.60
EV/Sales-135.62
Price$1.97
Change4.23%
Shares Out2.46M
Market Cap$4.92M
Enterprise Value$-11.36M
52W Range1.95 - 12.03
Beta1.22
P/E-0.54
P/S58.79
P/B0.29
P/FCF-0.60
EV/Sales-135.62
EV/EBITDA1.25
EV/FCF1.39
Earnings Yield-186.75%
FCF Yield-165.87%
Dividend Yield0.00%
Gross Margin-2.91%
Oper. Margin-93.13%
Profit Margin-95.52%
Debt/Eq0.00
Current Ratio14.81
Quick Ratio14.81
Revenue 5Y-74.69%
Volume106.54K
Avg Volume67.35K
EPS Surprise0.21
Investment DNA
How strong this company looks for long-term investors
37
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
70/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 14.81Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 2 analyst votes · 2026-10-20
75/100
Bullish
Bullish
1
Hold
1
Bearish
0
Insider Transactions
Recent executive and insider activity
Neal David K
Transaction: 06/11/2026
BUY
Change
+20,000
Price
Not reported
Filing
06/12/2026
Type
BUY
Thramann Jeffrey John
Transaction: 06/11/2026
BUY
Change
+100,000
Price
Not reported
Filing
06/12/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Deitsch Stephen | BUY | +20,000 | Not reported | 06/11/2026 | 06/12/2026 |
| Neal David K | BUY | +20,000 | Not reported | 06/11/2026 | 06/12/2026 |
| Thramann Jeffrey John | BUY | +100,000 | Not reported | 06/11/2026 | 06/12/2026 |
| Wesemann William | BUY | +20,000 | Not reported | 06/11/2026 | 06/12/2026 |
| Ness Brent | BUY | +100,000 | Not reported | 06/11/2026 | 06/12/2026 |
| Gould Gregory A | BUY | +50,000 | Not reported | 06/11/2026 | 06/12/2026 |
| Breidbart Scott | BUY | +20,000 | Not reported | 06/11/2026 | 06/12/2026 |
| Sequira Amanda Mae | BUY | +20,000 | Not reported | 06/11/2026 | 06/12/2026 |
| Bond Ryan | BUY | +55,000 | Not reported | 06/11/2026 | 06/12/2026 |
| Breidbart Scott | BUY | +5,664 | $3.18 | 05/12/2026 | 05/12/2026 |
| Neal David K | BUY | +2,500 | $3.10 | 05/11/2026 | 05/12/2026 |
| Ness Brent | BUY | +6,289 | $3.18 | 05/11/2026 | 05/11/2026 |
| Wesemann William | BUY | +1,562 | $3.30 | 05/06/2026 | 05/08/2026 |
| Ness Brent | BUY | +10 | $6.20 | 11/26/2025 | 12/01/2025 |
| Gould Gregory A | OTHER | 0 | Not reported | 09/02/2025 | 09/03/2025 |
| Gould Gregory A | BUY | +17,000 | $7.15 | 09/02/2025 | 09/03/2025 |
| Thramann Jeffrey John | SELL | -1 | $1000.00 | 03/28/2023 | 03/28/2023 |
| Thramann Jeffrey John | BUY | +1 | $1000.00 | 02/16/2023 | 02/21/2023 |
| Wesemann William | BUY | +63,000 | Not reported | 12/29/2022 | 12/29/2022 |
| Lorbiecki John Paul | BUY | +4,100 | $0.43 | 12/29/2022 | 12/29/2022 |